Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision log updated: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision: v3.4.3 has been added and v3.4.2 has been removed, updating the page’s revision label.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedStudy locations updated to 7 sites. Some site contacts and location details were removed (e.g., Allentown, PA / Lehigh Valley contact information).SummaryDifference0.7%

- Check37 days agoChange DetectedRevision: v3.4.2 was added to the page; the government funding lapse notice and related operating-status banner were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange DetectedThe page now displays a site-wide notice about a lapse in government funding and shows the site revision to v3.4.1, replacing v3.4.0. These changes are administrative and do not affect the study details, eligibility criteria, or outcomes.SummaryDifference0.4%

- Check51 days agoChange DetectedThe page now displays a glossary toggle and updated footer information including Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, replacing the previous labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.